| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 02/07/2002 | US20020015679 Bioconjugates of nanoparticles as radiopharmaceuticals |
| 02/07/2002 | DE10035156A1 New protein complex containing complex protein from botulinum toxin, useful for oral delivery of therapeutic polypeptide or low molecular weight pharmaceutical |
| 02/07/2002 | CA2771263A1 Therapeutic polyesters and polyamides |
| 02/07/2002 | CA2455170A1 Charged phospholipid compositions and methods for their use |
| 02/07/2002 | CA2417885A1 Cell internalized peptide-drug conjugates |
| 02/07/2002 | CA2417533A1 Pharmaceutical composition comprising a photochemotherapeutic agent and a mucoadhesive agent |
| 02/07/2002 | CA2417489A1 Use of indole derivatives for the manufacture of a medicament for reducing intracular pressure |
| 02/07/2002 | CA2417454A1 Peptide-mediated delivery of molecules into cells |
| 02/07/2002 | CA2417275A1 Transdermal drug delivery system |
| 02/07/2002 | CA2416978A1 Use of an aldehyde 5-oxo-1,2,4-triazine hydrazide for the treatment of cancer |
| 02/07/2002 | CA2416694A1 Paroxetine tablets and capsules |
| 02/07/2002 | CA2416122A1 Vaginal delivery of bisphosphonates |
| 02/07/2002 | CA2405728A1 Lipid-peptide conjugates for treatment of cancer |
| 02/07/2002 | CA2388550A1 Dispersions for formulating slightly or poorly soluble active ingredients |
| 02/06/2002 | EP1177217A1 Amphiphile cyclodextrins, preparation and use thereof for solubilising organised systems and incorporating hydrophobic molecules |
| 02/06/2002 | EP1177197A2 Polyamines and their use in therapy |
| 02/06/2002 | EP1176985A2 Enzymatically activated polymeric drug conjugates |
| 02/06/2002 | EP1176984A2 Medicament vehicle for the controlled administration of an active agent, produced from lipid matrix-medicament conjugates |
| 02/06/2002 | EP1176983A2 Hyperbranched polymeric micelles for encapsulation and delivery of hydrophobic molecules |
| 02/06/2002 | EP1176982A1 Prucalopride oral solution |
| 02/06/2002 | EP1176981A1 Treatment of autoimmune diseases with antagonists which bind to b cell surface markers |
| 02/06/2002 | EP1176962A2 Liposome compositions for improved drug retention |
| 02/06/2002 | EP1176961A2 Nicotine delivery systems |
| 02/06/2002 | EP1176951A1 Drug delivery device |
| 02/06/2002 | EP1176949A2 Lipid particles on the basis of mixtures of liquid and solid lipids and method for producing same |
| 02/06/2002 | EP1176948A1 Anti-nausea compositions and methods |
| 02/06/2002 | EP1176933A1 Topical medicated bioadhesive compositions and methods of use and preparation thereof |
| 02/06/2002 | EP1176877A1 Methods for lowering viscosity of glucomannan compositions |
| 02/06/2002 | EP1052987B1 Tablets to be crunched or sucked, comprising iron as active principle |
| 02/06/2002 | EP1001773B1 Oral solid pharmaceutical compositions containing nicorandil for a modulated release and the process for their preparation |
| 02/06/2002 | EP0977732B1 Amphiphilic compounds with at least two hydrophilic and at least two hydrophobic groups on a di- oligo- or polyene base |
| 02/06/2002 | EP0973710B1 Omega-amino acid derivatives, processes of their preparation and their use |
| 02/06/2002 | EP0914087B1 Use of fats to replace silicone in the production of cosmetic and/or pharmaceutical preparations |
| 02/06/2002 | EP0777487B1 Treatment of stroke associated with macrophage infiltration |
| 02/06/2002 | EP0731694B1 Opioid formulations for treating pain |
| 02/06/2002 | EP0729353B1 Preparation of biodegradable microparticles containing a biologically active agent |
| 02/06/2002 | EP0547163B1 Protein polyligands joined to a stable protein core |
| 02/06/2002 | CN1334834A Process for producing polymer |
| 02/06/2002 | CN1334830A Hydrophilic ampholytic polymer |
| 02/06/2002 | CN1334744A Medicinal aerosol formulation |
| 02/06/2002 | CN1334743A Method for accelerating rate of mucociliary clearance |
| 02/06/2002 | CN1334737A Aciclovir compositions contg. dimethicone |
| 02/06/2002 | CN1334729A Controlled-release dosage forms comprising zolpidem or salt thereof |
| 02/06/2002 | CN1334725A Parenteral solution of propofol (2,6-diisopropylphenol) and 2,5-di-O-methyl-1,4;3,6-dianhydro-D-glucitol as solvent |
| 02/06/2002 | CN1334724A Nanoparticulate core-shell systems and use thereof in pharmaceutical and cosmetic preparations |
| 02/06/2002 | CN1334723A Improvements in or relating to powder |
| 02/06/2002 | CN1334285A Polysaccharide material for direct tabletting |
| 02/06/2002 | CN1334124A Process for preparing natural percutaneous absorption promoter |
| 02/06/2002 | CN1334122A Medicine for treating HIV infection, its composition and its use |
| 02/05/2002 | US6344591 Bipyramidal or prismatic crystal structure; crystallizing a syrup having a maltitol content of >92% and a maltotriitol content of <1% controlling the crystal structure; free-flowing; antiagglomerants; foods; artificial sweeteners |
| 02/05/2002 | US6344576 Phospholipid-analogous compounds |
| 02/05/2002 | US6344488 Temperature-controlled pH-dependent formation of ionic polysaccharide gels |
| 02/05/2002 | US6344479 Amino acid salt of ibuprofen |
| 02/05/2002 | US6344446 Gene delivery |
| 02/05/2002 | US6344444 Arginine-silicate-inositol complex and use thereof |
| 02/05/2002 | US6344436 Gene delivery to cells |
| 02/05/2002 | US6344346 Polysaccharide, micro-organism and method for obtaining same, composition containing it and application |
| 02/05/2002 | US6344216 Conversion of powdered polymers |
| 02/05/2002 | US6344215 Methylphenidate modified release formulations |
| 02/05/2002 | US6344213 Compounds and compositions for delivering active agents |
| 02/05/2002 | US6344211 Releasing drugs to skin having absorption-increasing auxiliary agents; antibiotics, antipyretics, analgesics, anticoagulants, antidiabetic, cardiotonic, antispasmodic, hypotensive, anticholinergenic, antyarrthythmic agents |
| 02/05/2002 | US6344210 Composition for freshening nostrils and sinus cavities |
| 02/05/2002 | US6344206 Combination of a retinoid with a polyamine polymer |
| 02/05/2002 | US6344189 Topical administration of a serine protease inhibitor, such as pai-2. |
| 02/05/2002 | US6344182 Preparation of diagnostic agents by spray drying |
| 02/05/2002 | US6344050 For use in administering photodynamic therapy; conjugate of a microparticle, a photosensitizer, an antibody and a polymer |
| 02/05/2002 | CA2218289C Cd45rb binding compounds for the prevention of transplant rejection |
| 02/05/2002 | CA2150464C A pharmaceutical formulation for intraduodenal administration |
| 02/05/2002 | CA2051288C Viral targeted destruction of neoplastic cells |
| 02/05/2002 | CA2050623C Ointments containing tricyclic compound |
| 01/31/2002 | WO2002008470A1 Method for producing a crystalline tableting additive, additive thus obtained and use thereof |
| 01/31/2002 | WO2002008435A1 Codon-optimized papilloma virus sequences |
| 01/31/2002 | WO2002008426A2 Fh-binding protein of streptococcus pneumoniae |
| 01/31/2002 | WO2002008352A1 Medical contact adhesive comprising a two phase adhesive matrix of polyacrylates and polyamine salts |
| 01/31/2002 | WO2002008293A2 Multivalent target binding protein |
| 01/31/2002 | WO2002008182A1 Method for the production of a water-dispersible formulation containing carotenoids |
| 01/31/2002 | WO2002008174A1 Phenylethylamine derivatives and their use in the treatment of melanoma |
| 01/31/2002 | WO2002007813A1 Vaccines |
| 01/31/2002 | WO2002007783A2 Radiolabeled immunotoxins |
| 01/31/2002 | WO2002007780A2 Methods for identifying therapeutic targets |
| 01/31/2002 | WO2002007773A2 Multi-component biological transport systems |
| 01/31/2002 | WO2002007772A2 Improved oral dosage formulations |
| 01/31/2002 | WO2002007771A1 Pharmaceutically active compound |
| 01/31/2002 | WO2002007770A2 Polymeric conjugates of antitumor agents |
| 01/31/2002 | WO2002007769A1 A method of stabilisation and compositions for use therein |
| 01/31/2002 | WO2002007767A2 Pharmaceutical suspension compositions lacking a polymeric suspending agent |
| 01/31/2002 | WO2002007759A2 Clostridial toxin derivatives and methods for treating pain |
| 01/31/2002 | WO2002007748A2 Stimulation of cartilage growth with agonists of the non-proteolytically activated thrombin receptor |
| 01/31/2002 | WO2002007739A2 Pharmaceutical preparation for the treatment and diagnosis of tumors and method for the preparation of the lipid free fraction of blood plasma |
| 01/31/2002 | WO2002007738A1 Combinations of chitosan and psyllium for synergistic adsorption of triglyceride and cholesterol |
| 01/31/2002 | WO2002007736A1 The process for manufacturing of clear liquid pharmaceutical composition of azithromycin |
| 01/31/2002 | WO2002007730A1 Alpha v integrin receptor antagonists |
| 01/31/2002 | WO2002007728A1 Hair loss prevention |
| 01/31/2002 | WO2002007717A1 Emulsion of perfluororganic compounds for medical purposes, method for producing said emulsion and methods for curing and preventing diseases with the aid of the emulsion |
| 01/31/2002 | WO2002007712A2 Self-emulsifying drug delivery systems for extremely water-insoluble, lipophilic drugs |
| 01/31/2002 | WO2002007711A1 Compositions and films for capsule manufacture |
| 01/31/2002 | WO2002007708A1 Lyophilized powder of lentinan and the process of preparation thereof |
| 01/31/2002 | WO2002007707A2 Linkage of agents using microparticles |
| 01/31/2002 | WO2002007706A1 Method for coating solid particles with a thermofusible agent, and resulting coated solid particles |
| 01/31/2002 | WO2002007705A1 Carrier material for dry powder inhalation |